Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability
- PMID: 20099519
Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability
Abstract
Nanosuspensions of the anti-oxidant resveratrol (5%) were produced for dermal application. Production was performed by high pressure homogenization, applying 1.500 bar up to 30 cycles. Four nanosuspensions were investigated using the stabilizers Tween 80, Poloxamer 188, Plantacare 2000 and Inutec SP1, 1% and 2% respectively. The nanosuspensions were characterized regarding size (photon correlation spectroscopy, laser diffraction), zeta potential and crystallinity. Nanocrystal sizes were about 150 nm (Poloxamer, Plantacare) and about 200 nm (Tween, Inutec); no amorphous fraction could be detected in the nanocrystals. In a short-term stability study (30 days, room temperature), the nanosuspensions with 2% stabilizer proved to be either less stable or at least had no stability advantage over the 1% formulations. All formulations with 1% stabilizer were stable in the short-term study, Plantacare and Inutec showing best stabilization. The stabilization is attributed solely or mainly to steric stabilization, because the measured zeta potentials in the original dispersion media were close to zero (-1 to -5 mV, Tween, Poloxamer, Plantacare) or around -20 mV (Inutec).
Similar articles
-
Production and characterization of Hesperetin nanosuspensions for dermal delivery.Int J Pharm. 2009 Apr 17;371(1-2):182-9. doi: 10.1016/j.ijpharm.2008.12.030. Epub 2008 Dec 31. Int J Pharm. 2009. PMID: 19162147
-
Resveratrol nanosuspensions: interaction of preservatives with nanocrystal production.Pharmazie. 2011 Dec;66(12):942-7. Pharmazie. 2011. PMID: 22312699
-
Preserving hesperetin nanosuspensions for dermal application.Pharmazie. 2010 Feb;65(2):86-92. Pharmazie. 2010. PMID: 20225649
-
Stability of nanosuspensions in drug delivery.J Control Release. 2013 Dec 28;172(3):1126-41. doi: 10.1016/j.jconrel.2013.08.006. Epub 2013 Aug 14. J Control Release. 2013. PMID: 23954372 Review.
-
Pharmaceutical Strategies for Stabilizing Drug Nanocrystals.Curr Pharm Des. 2018;24(21):2362-2374. doi: 10.2174/1381612824666180515125247. Curr Pharm Des. 2018. PMID: 29766785 Review.
Cited by
-
Challenges, Unmet Needs, and Future Directions for Nanocrystals in Dermal Drug Delivery.Molecules. 2025 Aug 7;30(15):3308. doi: 10.3390/molecules30153308. Molecules. 2025. PMID: 40807482 Free PMC article. Review.
-
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.Front Pharmacol. 2020 Dec 30;11:619024. doi: 10.3389/fphar.2020.619024. eCollection 2020. Front Pharmacol. 2020. PMID: 33456444 Free PMC article. Review.
-
Resveratrol as a therapeutic agent for Alzheimer's disease.Biomed Res Int. 2014;2014:350516. doi: 10.1155/2014/350516. Epub 2014 Nov 26. Biomed Res Int. 2014. PMID: 25525597 Free PMC article. Review.
-
Impact of nanotechnology in cancer: emphasis on nanochemoprevention.Int J Nanomedicine. 2012;7:591-605. doi: 10.2147/IJN.S26026. Epub 2012 Feb 2. Int J Nanomedicine. 2012. PMID: 22346353 Free PMC article. Review.
-
Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.Drug Deliv Transl Res. 2014 Aug;4(4):365-76. doi: 10.1007/s13346-014-0201-3. Drug Deliv Transl Res. 2014. PMID: 25787068
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical